Building a Genetics Engine to Crack the Target Bottleneck

The Bio Report by Levine Media Group

A chronic shortage of high‑quality targets remains one of the biggest constraints in drug discovery, even as therapeutic tools become more powerful and diverse. Regeneron is tackling that problem with its Regeneron Genet...View more